Profound Medical Corp.

PROF · Nasdaq · SIC 3841: Surgical & Medical Instruments & Apparatus · Market Cap: $0.2B · 162 employees
180
SEC Filings
$6.67
Close 2026-06-01
162
Employees

Business Summary

Profound Medical Corp. is a commercial-stage medical device company focused on AI-powered, MRI-guided, incision-free therapies for ablation of diseased tissue. Its lead product, TULSA-PRO, uses real-time MRI, robotically-driven transurethral ultrasound, and closed-loop temperature feedback to ablate prostate tissue for cancer and BPH. Its Sonalleve system treats uterine fibroids, bone metastases, osteoid osteoma, and benign desmoid tumors. The company generates revenue from capital equipment sales and recurring one-time-use disposable devices.

Latest Stock Quote

PROF 2026-06-01 $6.67 O:$6.69 H:$6.85 L:$6.63 Vol:0.1M VWAP:$6.7341
origin leaf: fb4a0128361cfc3d78f30e646b1f9bbe7ca5e63c88c50b8918b50a4459a41cdd

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-052025-12-310001104659-26-024153EDGAR92K words
2025-03-072024-12-310001410578-25-000300EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-132025-09-300001104659-25-111378EDGAR17K words
2025-08-142025-06-300001410578-25-001809EDGAR—
2025-05-082025-03-310001410578-25-001112EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-04-010001171843-26-002146EDGAR1K words
2026-03-270001171843-26-001971EDGAR—
2026-03-130001171843-26-001553EDGAR—
2026-03-100001104659-26-025822EDGAR—
2026-03-090001171843-26-001406EDGAR—
2026-03-050001171843-26-001362EDGAR—
2026-02-120001171843-26-000791EDGAR—
2026-02-120001171843-26-000772EDGAR—
2026-02-050001171843-26-000643EDGAR—
2026-01-280001171843-26-000450EDGAR—

180 total filings indexed. 165 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

MMM — 3M CO ARAY — ACCURAY INC AEMD — AETHLON MEDICAL INC ALUR — ALLURION TECHNOLOGIES, INC. ANGO — ANGIODYNAMICS INC AORT — ARTIVION, INC. RCEL — AVITA Medical, Inc. ADGM — Adagio Medical Holdings, Inc.

Tags

prostate-cancer-treatment benign-prostatic-hyperplasia-(bph)-treatment uterine-fibroid-treatment bone-metastases-palliative-care osteoid-osteoma-treatment benign-desmoid-tumor-management mri-thermometry closed-loop-temperature-feedback-control focused-ultrasound ce-mark fda-class-ii-clearance hde-(humanitarian-device-exemption)

Company Identity

CIK0001628808
TickerPROF
ExchangeNasdaq
SIC3841: Surgical & Medical Instruments & Apparatus
IncorporatedA6
Websitehttps://www.profoundmedical.com
Listed2016-05-09

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: da297eb7cfff9eb60bb4f51db774e7e348db6d17dd16083609133cac7e819086
parent: a2dded2f1919e4655e1602b95ccc0a94dc61693c73e8ad40956b2bbd7e15b927
content hash: 5ab830819cc5dbc6481c0ac0d51f7d53b3a9f355812d74a3ea61a54513d7f612
signed: 2026-06-02T19:02:21.363Z
sources: 6 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf